Pan-Cancer Analysis of BUB1B/hsa-miR-130a-3p Axis and Identification of Circulating hsa-miR-130a-3p as a Potential Biomarker for Cancer Risk Assessment

<div>Further analysis of hub DEGs. (a) Clusters from MCODE in Cytoscape. (b) Overlapped genes of 5 different methods from CytoHubba plugin in Cytoscape. (c) Expression pattern of 4 overlapped genes in merged dataset (GSE13355 and GSE14905). (d) Expression pattern of 4 overlapped genes in GSE78097. (e) Expression pattern of 4 overlapped genes in GSE55201.</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: Pan-Cancer Analysis of BUB1B/hsa-miR-130a-3p Axis and Identification of Circulating hsa-miR-130a-3p as a Potential Biomarker for Cancer Risk Assessment 

Figure 4 | Pan-Cancer Analysis of BUB1B/hsa-miR-130a-3p Axis and Identification of Circulating hsa-miR-130a-3p as a Potential Biomarker for Cancer Risk Assessment 